Aditya Birla Sun Life Pharma & Healthcare Fund Direct Payout Inc Dist cum Cap Wdrl

Equity
Direct
Sector - Healthcare
Aditya Birla Sun Life Pharma & Healthcare Fund Direct Payout Inc Dist cum Cap Wdrl

About the Fund

Aditya Birla Sun Life Pharma & Healthcare Fund Direct Payout Inc Dist cum Cap Wdrl is an equity fund. This fund was started on 11 July, 2019. The fund is managed by Dhaval Shah. The fund could potentially beat inflation in the long-run.

Key Parameters

  1. Aditya Birla Sun Life Pharma & Healthcare Fund Direct Payout Inc Dist cum Cap Wdrl has ₹713 Cr worth of assets under management (AUM) as on Jun 2024 and is less than category average.
  2. The fund has an expense ratio 1.

Returns

Aditya Birla Sun Life Pharma & Healthcare Fund Direct Payout Inc Dist cum Cap Wdrl has given a CAGR return of 22.88% since inception. Over the last 1, 3 and 5 years the fund has given a CAGR return of 37.80%, 12.56% and 22.90% respectively.

Holdings

Aditya Birla Sun Life Pharma & Healthcare Fund Direct Payout Inc Dist cum Cap Wdrl has allocated its funds majorly in Cash Equivalent, Health, Financial Services, Basic Materials. Its top holdings are Sun Pharmaceuticals Industries Ltd, Cipla Ltd, Torrent Pharmaceuticals Ltd, Apollo Hospitals Enterprise Ltd, Aurobindo Pharma Ltd

Taxation

As it is a sector - healthcare mutual fund the taxation is as follows:
For short term (less than a year) capital gains will be taxed at 15%
For long term (more than 1 year) capital gains will be taxed at 10% without indexation benefit
Dividends will always be taxed at slab rate. Gains upto Rs 1 lakh are exempt in case of long term.

Investment objective of Aditya Birla Sun Life Pharma & Healthcare Fund Direct Payout Inc Dist cum Cap Wdrl

The scheme provides long term capital appreciation by investing in equity/equity related instruments of the companies in the Pharmaceuticals, Healthcare and Allied sectors in India. The Scheme does not guarantee/indicate any returns. There can be no assurance that the schemes’ objectives will be achieved.

Minimum Investment and lockin period

Minimum investment for lump sum payment is INR 1000.00 and for SIP is INR 100.00. Aditya Birla Sun Life Pharma & Healthcare Fund Direct Payout Inc Dist cum Cap Wdrl has no lock in period.

Fund Performance
zero opening, trading, fund transfer fee
7 people have invested ₹ 9K in Aditya Birla Sun Life Pharma & Healthcare Fund Direct Payout Inc Dist cum Cap Wdrl in the last three months

Fund Overview

Expense ratio1.01%
Benchmark
S&P BSE Healthcare PR
AUM₹713 Cr
Inception Date11 July, 2019
Min Lumpsum/SIP₹1000/₹100
Exit Load
1%
Lock InNo Lock-in
TurnOver
30.7%
Risk
Risk meter
pointer
Very High Risk

Fund Distribution
as on (30-Jun-24)

  • Equity 96.6%

  • Debt & Cash 3.4%

Large cap
41.6%

Mid cap
35.7%

Small cap
18.2%

Sector Allocation

May'24

Apr'24

Mar'24

Health
97.1%
Financial Services
1.9%
Basic Materials
1%
All changes are between Apr'24 and Jun'24

Dhaval Shah
Dhaval Shah
Fund Manager of Aditya Birla Sun Life Pharma & Healthcare Fund Direct Payout Inc Dist cum Cap Wdrl, since 11 July 2019

Aditya Birla Sun Life Pharma & Healthcare Fund Direct Payout Inc Dist cum Cap Wdrl Highlights

Risk meter
pointer

Very High Risk

Investors understand that their principal will be at Very High Risk
About the fund

About the fund

This fund has delivered an average annual returns of 22.88% since inception which is less than its category average return of 23.03%
Fund Allocations

Fund Allocations

This fund has an allocation of 96.59% in Equity, 0% in Debt and 3.41% in Cash related instruments
AUM size ₹713 Cr

AUM size ₹713 Cr

This fund has AUM of ₹713 Cr which is less than its category average of ₹ 1735 Cr
Expense Ratio 1.01%

Expense Ratio 1.01%

This fund has an expense ratio of 1.01% which is less than its category average expense ratio of 1.45%

Frequently Asked Questions

The current NAV of Aditya Birla Sun Life Pharma & Healthcare Fund Direct Payout Inc Dist cum Cap Wdrl is ₹22.75 as on 12-Jul-2024.
Existing (Absolute + CAGR) as on 12-Jul-2024.
Aditya Birla Sun Life Pharma & Healthcare Fund Direct Payout Inc Dist cum Cap Wdrl
Absolute Returns
CAGR Returns
1 Month Returns
3.64%
3.64%
6 Month Returns
15.84%
15.84%
1 Year Returns
37.8%
37.8%
3 Years Returns
42.62%
12.56%
5 Years Returns
180.33%
22.9%
With INDmoney, the process of investing is very simple and involves zero commission.
  • Click Buy on the fund name.
  • Input the amount you are looking to invest.
  • Select Lump Sum or SIP (Weekly, Monthly or Quarterly).
  • Select your bank account and proceed with Payment.
1.01% as on June 2024
₹713 Cr as on June 2024
Sun Pharmaceuticals Industries Ltd(14.63%), Cipla Ltd(8.72%), Torrent Pharmaceuticals Ltd(7.62%), Apollo Hospitals Enterprise Ltd(6.41%), Aurobindo Pharma Ltd(5.78%) as on June 2024
Health(93.6%), Financial Services(1.94%), Basic Materials(1.05%) as on June 2024
The alpha ratio for the Aditya Birla Sun Life Pharma & Healthcare Fund Direct Payout Inc Dist cum Cap Wdrl for various period is as follows:
Fund Name
Alpha 1 Year
Alpha 3 Years
Alpha 5 Years
Aditya Birla Sun Life Pharma & Healthcare Fund Direct Payout Inc Dist cum Cap Wdrl
-6.3
-1.61
-
As on June 2024
The alpha for Aditya Birla Sun Life Pharma & Healthcare Fund Direct Payout Inc Dist cum Cap Wdrl is calculated against S&P BSE Healthcare PR. Higher alpha indicates that this fund has generated extra returns compared to the benchmark index. An alpha of 1.0 means the fund has outperformed its benchmark index by 1%.
The Beta ratio for the Aditya Birla Sun Life Pharma & Healthcare Fund Direct Payout Inc Dist cum Cap Wdrl for various period is as follows:
Fund Name
Beta 1 Year
Beta 3 Years
Beta 5 Years
Aditya Birla Sun Life Pharma & Healthcare Fund Direct Payout Inc Dist cum Cap Wdrl
0.95
0.93
-
As on June 2024
The Beta for Aditya Birla Sun Life Pharma & Healthcare Fund Direct Payout Inc Dist cum Cap Wdrl is calculated with S&P BSE Healthcare PR. Beta tells the volatility of the mutual fund relative to its benchmark. If the beta of a mutual fund is more than 1, then the mutual fund is more volatile than its benchmark. If beta is less than 1, then the mutual fund is less volatile than the benchmark.
The sharpe ratio for the Aditya Birla Sun Life Pharma & Healthcare Fund Direct Payout Inc Dist cum Cap Wdrl for various period is as follows:
Fund Name
Sharpe Ratio 1 Year
Sharpe Ratio 3 Years
Sharpe Ratio 5 Years
Aditya Birla Sun Life Pharma & Healthcare Fund Direct Payout Inc Dist cum Cap Wdrl
1.47
0.43
-
As on June 2024
The sharpe ratio for Aditya Birla Sun Life Pharma & Healthcare Fund Direct Payout Inc Dist cum Cap Wdrl is calculated with S&P BSE Healthcare PR. Sharpe ratio tells risk-adjusted-returns of the mutual fund. The higher a fund's Sharpe ratio, the better a fund's returns have been relative to the risk it has taken on.
The standard deviation for the Aditya Birla Sun Life Pharma & Healthcare Fund Direct Payout Inc Dist cum Cap Wdrl for various period is as follows:
Fund Name
Standard Deviation 1 Year
Standard Deviation 3 Years
Standard Deviation 5 Years
Aditya Birla Sun Life Pharma & Healthcare Fund Direct Payout Inc Dist cum Cap Wdrl
16.24
15.1
-
As on June 2024
Standard deviation tells the volatility of the returns of the mutual fund. The higher a fund's Standard deviation, the higher the volatility of the fund's returns.
Sortino ratio is 0.72 as on June 2024. Sortino ratio tells the downside risk-adjusted-returns of the mutual fund.
Dhaval Shah is the fund manager of Aditya Birla Sun Life Pharma & Healthcare Fund Direct Payout Inc Dist cum Cap Wdrl
The Exit load of Aditya Birla Sun Life Pharma & Healthcare Fund Direct Payout Inc Dist cum Cap Wdrl is 1%